Skip to main content
  • Research article
  • Open access
  • Published:

Can mentorship improve laboratory quality? A case study from influenza diagnostic laboratories in Southeast Europe



Strengthening the quality of laboratory diagnostics is a key part of building global health capacity. In 2015, the Centers for Disease Control and Prevention (CDC), the Southeast European Center for Surveillance and Control of Infectious Diseases (SECID), WHO European Regional Office (WHO EURO) and American Public Health Laboratories (APHL) collaborated to address laboratory quality training needs in Southeast Europe. Together, they developed a quality assurance (QA) mentorship program for six national laboratories (Laboratories A-E) in five countries utilizing APHL international consultants. The primary goal of the mentorship program was to help laboratories become recognized by WHO as National Influenza Centers (NICs). The program aimed to do this by strengthening influenza laboratory capacity by implementing quality management systems (QMS) action steps. After 1 year, we evaluated participants’ progress by the proportion of QMS action steps they had successfully implemented, as well as the value of mentorship as perceived by laboratory mentees, mentors, and primary program stakeholders from SECID and WHO EURO.


To understand perceived value we used the qualitative method of semi-structured interviews, applying grounded theory to the thematic analysis.


Mentees showed clear progress, having completed 32 to 68% [median: 62%] of planned QMS action steps in their laboratories. In regards to the perceived value of the program, we found strong evidence that laboratory mentorship enhances laboratory quality improvement by promoting accountability to QMS implementation, raising awareness of the importance of QMS, and fostering collaborative problem solving.


In conclusion, we found that significant accomplishments can be achieved when QA programs provide dedicated technical mentorship for QMS implementation. Since the start of the mentoring, Laboratory “B” has achieved NIC recognition by WHO, while two other labs made substantial progress and are scheduled for recognition in 2018. In the future, we recommend that mentorship is more inclusive of laboratory directors, and that programs evaluate the amount of staff time needed for mentorship activities, including lab-based assessments and mentoring.

Peer Review reports


Within the World Health Organization’s Global Influenza Surveillance and Response System (GISRS), National Influenza Centers (NICs) are responsible for collecting, evaluating, and sending viral specimens to WHO Collaborating Centers (WHO CCs). Annually, the WHO CCs identify the most representative influenza strains for use in global vaccine production. NICs also share the types of influenza viruses circulating weekly via the virologic monitoring platform, WHO FluNet. To become a NIC, an institution must be designated by the country’s ministry of health and formally recognized by WHO through an assessment process [1, 2]. As one of the six WHO CCs for Influenza, the Centers for Disease Control and Prevention (CDC) aims to strengthen global influenza surveillance by improving laboratory quality and increasing the number of laboratories that contribute to GISRS as NICs [3].

To further these efforts, in 2005 CDC collaborated with the Association of Public Health Laboratories (APHL), and together, they established a group of U.S. public health laboratory experts to serve as international consultants with specific expertise in laboratory systems and influenza laboratory diagnostics [4]. In 2015, seeking to address quality improvement needs in Southeast Europe, the CDC, the Southeast European Center for Surveillance and Control of Infectious Diseases (SECID), WHO European Regional Office (EURO) and APHL formed a collaborative mentorship program. Together, they developed a quality management (QMS) mentorship framework that utilized APHL consultants as mentors. The primary goal of the mentorship program was to help national influenza laboratories become National Influenza Centers (NICs) officially recognized by WHO. By mentoring laboratories through the process of implementing QMS action steps it was hoped that laboratories could close quality gaps, and eventually operate as a NIC within the GISRS network (Fig. 1).

Fig. 1
figure 1

Description of Mentorship Program

Six laboratories (designated A-E) from five countries were included in the program: Albania, Bosnia and Herzegovina (Sarajevo & Banja Luka), Kosovo, Macedonia and Montenegro. One country, Albania, was already a WHO recognized NIC; however, due to challenges with maintaining capacity and quality improvement, implementing partners in the region agreed that the lab could also benefit from mentorship.

Prior to the mentorship initiation the laboratories participated in a training conducted by KIT (Royal Tropical Institute) and EURO on the WHO Laboratory Quality Stepwise Implementation (LQSI) tool which guides laboratories toward implementing a QMS in accordance with the International Organization for Standards (ISO) 15,189 requirements [5, 6]. A mentor and mentee can download specific LQSI step-wise implementation checklists (and associated standardized templates and examples) based on the LQSI phases and modules that are of priority [6]. In addition, the mentee’s laboratory was also assessed by their mentor using the CDC-APHL International Influenza Laboratory Capacity Review Tool that provided them lab-specific recommendations (hereon referred to as “assessment recommendations”) at the launch of the mentorship project [7]. The capacity review tool was designed with the capacities for meeting NIC terms of reference in mind. Assessment recommendations that result from the tool help to identify potential areas for technical assistance specifically related to influenza diagnostics. By translating both the LQSI tool and assessment recommendations into QA mentorship action plans (heron referred to as “action plans”), the laboratories can work simultaneously on QMS improvements and capacity building that contributes to meeting or maintaining NIC terms of reference (Fig. 1, Table 1). The plans vary based on each laboratory’s unique context. They serve as a framework for the program to monitor and evaluate progress, and whether they may be ready to perform adequately as a NIC in the region. A comparison of focus areas for the NIC Terms of Reference (ToR), CDC-APHL International Influenza Laboratory Capacity Review Tool, and WHO Laboratory Quality Stepwise Implementation (LQSI) tool are provided in Table 1 [2, 6, 7].

Table 1 Comparison of focus areas in the NIC terms of reference (ToR), CDC-APHL International Influenza Laboratory Capacity Review Tool, and the WHO Laboratory Quality Stepwise Implementation (LQSI) tool

Mentor selection

CDC and APHL selected four mentors to mentor six labs, resulting in two mentors doubling up on mentees. Mentors were able to commit to 12 months of engagement, and had a minimum of 15 years’ experience in public health laboratories. Additionally, all mentors had conducted international influenza laboratory capacity reviews, and therefore had a solid grounding in international capacity building engagement, expertise, culture and leadership.

Mentee selection

All participating laboratories were formerly designated by their respective ministries of health to perform influenza virological surveillance. Accordingly, each ministry of health nominated influenza laboratory staff members to participate in this program. The size of each laboratory varied from just two staff to 15 staff, with most staff rotating to other areas of the laboratory as needed. Likewise, the total number of specimens processed for influenza results during the evaluation period varied from 82 specimens to 775, with two laboratories having no results available on the GISRS open-access, global virologic monitoring platform, FluNet (Table 2). All of the laboratories selected for this program also participate in the surveillance and control of communicable disease activities of the Southeastern Europe Health Network, coordinated by the Southeast European Center for Surveillance and Control of Infectious Diseases (SECID). Additionally, SECID together with all laboratories contribute to the implementation of the project “Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities of Countries of South East Europe” supported through a cooperative agreement with the United States Centers for Disease Control and Prevention that also provides technical support coordinated with the WHO/Europe.

Table 2 Laboratory capacity


Mentors discussed challenges and progress with mentees on a monthly basis via email and telephone, and tracked progress using the action step Gantt chart that they co-developed together following the LQSI training. To facilitate communication and sharing of documents, EURO set up an EZCollab document-sharing website for mentors and mentees.

We conducted an internal, formative evaluation of the program (July 2015—June 2016) to answer the following evaluation questions:

  • To what extent were QA action plans achieved?

  • What was the perceived value of a mentorship program in the Southeast European region?

This paper responds to these questions through a discussion of the progress and observations made after the first year of mentorship.


To evaluate progress, we measured the percentage of the action plan steps that were in a status of completed, in progress, and without progress as reported and validated by mentors and mentees after one year. We utilized qualitative methods as a formative approach to evaluating the perceived value of mentorship and the lessons learned [8,9,10]. To support the heterogeneity of the differing laboratory contexts, we utilized grounded theory, which allows for the unique experiences of each laboratory and mentor to be discussed and facilitated through a standard methodology [11]. Over 5 days, a trained qualitative evaluator from CDC who was not familiar with the program, and did not participate in the program, conducted face-to-face, semi-structured interviews with the six laboratory mentees and four mentors (26 questions), with a stakeholder from WHO regional office for Europe most directly involved in the program (14 questions) and with one key stakeholder from SECID who is responsible for coordinating capacity building for influenza infectious disease surveillance in the region (14 questions). This resulted in a total of 282 questions coded [6 mentee transcripts with 26 questions, 4 mentor transcripts with 26 questions, and 2 stakeholder transcripts with 14 questions] (Additional file 1: Appendix A. Example Survey Questions). APHL and CDC vetted the interview questions among laboratory subject matter experts. The general topic guide included the following: 1) development of the quality improvement plan, 2) connection to and follow-up with APHL mentor/mentee over the course of the year, 3) implementation guidance and support, 4) long-term results of the project & progress towards NIC requirements and/or designation, 5) lessons learned about technical mentorship for laboratory quality improvement. A note-taker who also did not participate in the program, recorded written transcripts of the interviews. Interview times ranged from 60 to 86 min. This was a convenience sample specifically chosen for program evaluation; therefore, all program participants were interviewed and there was no saturation point [12, 13].

A program evaluator with qualitative analysis training independently coded transcripts using grounded theory to identify themes, and to later analyze and interpret them through content analysis [11, 12, 14] . Cleaned transcripts were organized into Microsoft Excel by respondent and question number, and codes and sub-codes were manually entered for each question. Due to the hand-written nature of the notes, we uncovered instances where some of the interview notes did not provide enough of the discussion to accurately code. In these cases, we coded the response as ‘missing’ rather than attempting to guess. To validate the reliability of coding, a second-coder was trained to independently code the transcripts in a separate Excel workbook. The question codes across the 12 transcripts (N = 6 mentees, 4 mentors, and 2 stakeholders) were compared, and resulted in an agreement of 86% across all interview transcript questions (n = 241/282). The 14% (n = 41/296) discrepant codes were resolved through discussion. We opted for using % comparison as a measure of reliability, with two coders directly coding all questions independently, because our purpose was coming to consensus in interpretation for all themes in our evaluation, rather than determining the accuracy of applying finalized, pre-set codes to a larger data set [12,13,14].

Evaluation assumptions

It is important to note that the number and type of action steps developed for each laboratory differs. This necessarily reflects differing phases of development, capacity, and resources. Rather than emphasizing the same action steps across laboratories, all mentors emphasized choosing steps that were a priority and were feasible to achieve in one year, based on the laboratories unique situation (Fig. 1).


Prioritizing which areas to improve

The total number of action steps from each national lab ranged from 9 to 62 [median = 22]. A median of 55% (IQR 43–67%) of the assessment recommendations were translated into action steps (Table 3).

Table 3 Status of action steps after one year

When asked openly about what helped mentees and mentors to choose action steps for quality improvement, the LQSI process was stressed by the majority (n = 5/6 mentees; and 2/4 mentors). We heard that “The LQSI tool (Laboratory Quality Management tool) helped to guide the process (it was the Bible)” and that it was “useful for their staff members to write the action plan about how to train other laboratorians to help in the influenza laboratory. [We brought] back a retired person to assist in the influenza laboratory - the action plan was the driver of that change.” (Mentee). Another mentee explained that, “The APHL-CDC International Influenza Laboratory Capacity Review is more science based, so using the LQSA tool helped ‘pinpoint’ issues with process.” When probed, all laboratories, regardless of NIC status or capacity, reported that the LQSI tool was advantageous and no mentor or mentee reported it disadvantageous. Equally stressed as important for choosing action steps were the assessment recommendations (n = 4/6 mentees; 3/4 mentors). When probed, one of the mentors reflected that, “The capacity lab assessment helped to frame the ideas to help push along. If the mentorship program were recreated, a laboratory assessment is critical or at least review of a previous assessment.” Upon further questioning, mentees reflected that the assessment recommendations helped influence the “credibility” of the action plan itself given the more extensive understanding of the national laboratory by the mentor and mentee (n = 5/6 mentees).

Fostering accountability was key to progress made

After one year, 32 to 68% of QMS action steps were completed [median: 62%] (Table 3). Due to the translation of 21 to 86% of assessment recommendations into action steps, a median of 58% of assessment recommendations were also completed through the process of completing action steps.

All mentees (n = 5/6, 1 missing) and mentors (n = 4/4) felt that mentorship was critical to fostering implementation of QMS through accountability. “Without mentorship the accomplishments would not have happened. It definitely made [us] more accountable, [and] pushed [us] to complete tasks” (mentee). Each mentor further stressed the value of accountability. “The mentorship program was a good accountability measure because they know every month they will be asked about progress,” and “[the] advantage of the mentorship program [was that it] laid out expectations and a timeline. These two things are very important” (mentor). Mentees highlighted the value of having regular discussions with their mentors (n = 4/6 mentees), and designating a quality assurance manager or team inside of the laboratory that was responsible for advancing actions for quality improvement (n = 2/6 mentees). In regards to the differences between being a mentor and a laboratory assessor, we heard that “as an assessor you come in and make recommendations and [the labs] don’t have anyone to go to get the recommendations accomplished, versus mentorship, which gives them recommendations and someone to work with to accomplish the recommendations.” Another mentor saw the value of mentorship versus laboratory assessment as helping to shape the acceptance of quality management systems, “it help[s] the country understand why this all is important and not just a recommendation” (mentor).

The action items were organized in a Gantt chart for monthly progress reporting, which according to all mentors was effective for helping them to visually track progress and anticipate future needs from their mentees (n = 4/4 mentors). WHO and SECID stakeholders were satisfied with the content of these reports and felt that it enabled effective follow-up (n = 2/2). All mentees who responded felt that the communication with their mentor, whether weekly, bi-weekly, or monthly was satisfactory, while two of the four mentors expressed a desire to have communicated more often. Mentors struggled to maintain monthly follow-up on progress, particularly when laboratory staff were on vacation. They described all communication as “mentor-initiated,” and expressed a desire for laboratories  to take more ownership of the process. Three of the mentees agreed that follow-up was mentor initiated, while two felt equal initiation (n = one missing from transcript).

The program helped address implementation challenges

There were two common themes regarding challenges to implementing the action plans. The first was the need for cultural and behavioral changes within the laboratory. Sub-themes described were a lack of wider staff involvement and motivation to perform routine quality management. One explanation given was that it is not yet being institutionalized as a part of the laboratorians’ jobs (n = 3/6 mentees, n = 1/4 mentors). In close connection, the lack of support from management and decision makers to implement quality improvements was another important sub-theme (n = 3/6 mentees, n = 1/4 mentors). One mentee commented that, “getting people involved and to understand, especially at higher levels, is a challenge. Overcoming is hard and [I] continue to try. The mentoring program was a kick off point to build the culture and it would be helpful to get upper management involved from the beginning.” The second theme regarding challenges was management of resources (n = 4/6 mentees, 1/4 mentors) including shortages of staff and routine training for staff, reagent procurement, and equipment maintenance.

Most mentees (n = 4/6 mentees, n = 2 missing) and mentors (n = 3/4 mentors, n = 1 missing) reported that the mentor program helped to address these challenges. Specific sub-themes mentioned were advocacy and awareness raising (n = 2/6 mentees, n = 1/4 mentors), improvement of standard operating procedures (n = 1/4 mentor), providing general guidance and accountability on how to approach quality improvement implementation (n = 2/6 mentees), and getting internal buy-in for QMS support through SECID’s involvement (n = 1/6 mentees, n = 1/4 mentors). Mentorship itself, in terms of being connected to a mentor, stood out as the most common “tool” mentioned for QMS problem solving (n = 6/6 mentees). Sub-themes were mentors’ abilities to draft a letter to the director to raise awareness of issues (n = 1/6), perform laboratory assessments (n = 2/6), solve technical problems (n = 2/6) and the mentee’s accountability to their mentor for deadlines and actions related to quality improvement plans (n = 2/6). Both mentees and mentors described SECID’s role as very influential due to their pre-existing relationships with the ministries of health and laboratory directors. Specific sub-themes related to their value as collaborators were creating an open, extended network of partners, logistic support of laboratory purchases connected to NIC functions, and support of internal management within the laboratory (n = 4/6 mentees; n = 2/4 mentors). “SECID was really important. [Laboratory staff] are used to working with SECID and already had the relationship” (mentor).

Before the program began, mentees reported that it was “somewhat difficult” to address quality improvement. After one year, all mentees felt it had become somewhat easy to very easy (n = 6/6 mentees). This was validated by mentors also felt each laboratory moved from an area of “somewhat difficult” to “somewhat easy” (n = 4/4 mentors). Table 4 presents the types of progress described by mentees or mentors. “[It’s the] tip of iceberg – no one spoke of laboratory acquired infection prior to this program and also biosafety. Culture and behavior change [occurred] overall” (mentee). In addition, mentees found the program to be very impactful (n = 3/6) or critical (n = 3/6) to their quality improvement. One mentor verified this stating that, “Laboratories are seeing progress and are able to accomplish items,” and “[there is] overall improvement in processes. [They] now have Standard Operating Procedures in place [which is] a major improvement [in] the actual flu surveillance rather than just diagnostic [methods]” (mentor). Mentees also reported improved skills through the mentorship program. Sub-themes included skills in management, organization and evaluation, and an increased ability to identify and plan for ways to address quality improvement issues. “Success has been better having CDC, APHL, and SECID behind [me] for credibility; [I] am more confident, and understanding how other labs [do quality improvement] is helpful” (mentee).

Table 4 The types of progress observed by mentees or mentors
Table 5 Sections of SLIPTA

Achieving National Influenza Center (NIC) designation

When we collected data for this evaluation, virus isolation capabilities, such as cell culture, were a required NIC function. In relation, mentees stated that the area of most concern for achieving and maintaining NIC requirements was virus isolation [2]. All of the action plans included at least two action steps aimed at improving virus isolation. The overall progress made across the different NIC requirements was reported as difficult to discern by both mentees and mentors (n = 6/6 mentees, 4/4 mentors). Never the less, mentors felt that the program was somewhat important to the laboratory’s ability to make overall progress toward NIC designation. At the time of data analysis, in addition to NIC-ALB which annually maintains the status of WHO recognition, Laboratory “B” achieved WHO NIC recognition. Three other laboratories have also made substantial progress with Laboratory “F” scheduled for recognition in 2018 and Laboratory “D” and “E” in the first quarter of 2019. After the evaluation period, WHO decided to eliminate virus isolation from being a required part of the NIC terms of reference going forward, which could impact the way in which action steps related to virus isolation are approached and prioritized in the future [15].

Improvements beyond influenza diagnostics

The impact of quality improvements extended beyond influenza diagnostics. Four mentees mentioned changes in other laboratories (n = 4/6) and this was validated by each mentor (n = 4/4). “[Quality improvements] expanded to the entire virology department and helped to identify issues in measles. The QA was designed to address the whole laboratory from the beginning” (mentee). “[We] have just started training the whole department on QMS and training on biosafety and biosecurity is [the] next step. Most [staff] do not have this knowledge because it is not in [the] school curriculum. [So] they are now instituting an internal training process in the department, and QMS is a part of the material and curriculum” (mentee).

Recommendations from laboratories, mentors and WHO

To improve the QMS laboratory mentorship programs, mentees suggested organizational changes that support laboratory quality improvement such as management support of laboratory staff conducting QMS activities. This included supporting team building for quality assurance and clearer roles and responsibilities for staff. Mentors recommended scheduling a minimum time commitment from the laboratory devoted to quality management activities, such as 20% of staff time per week. Mentors also recommended that the program begin with a laboratory assessment that is re-assessed after 1–2 years, as well as equipping the document sharing platforms, such as EZCollab, with all reference documents at the beginning of the program. Stakeholders from WHO and SECID commented that the multi-partner approach worked well. They defined this approach as working with a WHO regional office through the existing WHO GISRS network, having laboratory mentorship from trained APHL consultants, focusing on national public health laboratories with an interest in improving capacity, having a technical implementation partner such as CDC, and having a local, grant-funded, regional collaborator with pre-established relationships with decision makers such as SECID. In this case, “It [is] a combination of mentoring, the CDC Cooperative Agreement funding with SECID through which countries get resources to buy reagents, and the support from WHO in terms of training. It is really a constellation of partners and support. Because if you’re assigned a mentor without the other two partners, you have a recommendation, but not the means to do it” (stakeholder).


We describe our evaluation in relation to two questions: (1) to what extent were QA action plans achieved?, and (2) what was the perceived value of a laboratory quality mentorship program?

In evaluating our first question, we found that each laboratory created action plan steps (median 22 per laboratory) geared to improve laboratory capacity and gain NIC status, and 61% of planned action steps were complete after one year, demonstrating clear progress. In regards to our second question, the program enhanced accountability for implementing planned actions and increased awareness of the importance of quality management processes in a laboratory, extending beyond the influenza laboratory. We discovered that mentees and mentors perceived the mentorship program as beneficial to addressing barriers to laboratory quality improvement. Moreover, laboratory "B" achieved the goal of NIC recognition, while laboratory "F" earned an official assessment in 2018, followed by planned assessments for laboratories "D" and "E" in 2019.

Laboratory quality improvement seems to be a growing area within international laboratory capacity building. In a 2010 review of published reports, major donor interviews, and case studies of laboratory systems in three resource-limited countries Olmsted et al. recommends that, “host countries and their external partners should incorporate laboratory standards, comprehensive quality systems, and even goals for accreditation in their plans for laboratory development” [16]. Although NIC recognition is not comparable to accreditation, it does provide a standard for operation, and creates a network and connection to other laboratories and external agencies through WHO GISRS.

Three other international QMS mentorship models also offer lessons learned [5, 17, 18] . Peronne et al. implemented a QMS mentorship model in Southeast Asia to strengthen the quality and capacity of Cambodian hospital laboratories [5]. By recruiting and training four local laboratory technicians, they mentored staff from 12 hospitals on QMS practices, and used the LQSI tool as their primary assessment tool translated into Khmer – one of the local languages. According to Peronne et al. “project staff reviewed the laboratories’ progress and challenges in weekly conference calls and bi-monthly meetings with focal points of the health ministry, participating laboratories and local partners” [5]. After 18 months, 12 laboratories had completed 74–90% of the 104 activities in phase 1, 53–78% of the 178 activities in phase 2, and 18–26% of the 129 activities in phase 3. They highlight the importance of imbedding mentorship into the worksite and using local languages; however, caution that for the majority of laboratories in developing countries, accreditation, emphasized in the final phase of the LQSI tool, is not feasible due to resource and capacity constraints, potentially limiting the scope and effectiveness of assessment tools like the LQSI alone.

In the African region, for example, Alemenjii et al. points out that accreditation is still not cost-effective for the majority of laboratories [19]. In a review of laboratory strengthening in sub-Saharan Africa, they found that achieving practical and sustainable laboratory accreditation was a major challenge owing to “lack of leadership, attention, resources and commitment” [19]. Of the over 340 accredited laboratories in Africa, they find that 312 (92%) were located in South Africa alone which is a country with a national accreditation body; the South African National Accreditation System [20]. While utilizing local languages and regional staff should absolutely be considered in easing the cultural and technical language barriers of global laboratory mentorship, our program’s hybrid approach of combining the LQSI approach with a standard assessment of the influenza laboratories without the emphasis on accreditation could offer an advantage.

Another program, which can be compared, is the Stepwise Laboratory Quality Improvement Process Toward Accreditation (SLIPTA). Maruta et al., describes a SLIPTA mentorship program at three district and one central laboratory in Lesotho, which aimed to help with accreditation, a similar focus to Peronne et al. [5, 17, 18]. Their model had a mentor from the Southern Africa region fully embedded within the operations of each of the laboratories for an initial six-week and then a follow-up four-week visit, separated by 6–8 weeks. Quality improvements measured at baseline using the SLIPTA check-list improved significantly in all four laboratories after 10 weeks, with the central laboratory progressing significantly after just 5 weeks (from 44 to 57% completed steps; p = 0.021) [18]. Like our model, the SLIPTA model formulated action plans jointly with mentors using a standardized tool, in their case the SLIPTA checklist that resulted in a type of Gantt chart with activities, responsible person, timeline, and review dates, which became a working document with a defined improvement path. The major difference in the SLIPTA program compared to ours was the presence of the mentor in the lab for 10 weeks following the baseline assessment, versus a one-week baseline assessment visit with associated recommendations. The SLIPTA mentor also mentored the entire lab, not just one mentee, and offered group discussions and presentations for the entire laboratory once every week on topics identified by the baseline assessment. They also held staff meetings to give advice and coaching on issues arising from the lab.

While this immersed, work-based approach could be an advantage of the SLIPTA mentoring program; one of the major reported drawbacks is cited by Yao et al. who cautions that areas not addressed in depth by SLIPTA (Table 5) include quality control principles and practices, writing standard operating procedures, biologic safety, and quality assurance manager training. However, improved standard operating procedures and biosafety actions have been identified as key barriers for the improvement of international laboratory capacity through the CDC-APHL capacity review tool [17, 21]. The sustainability of changes facilitated during intensive mentorship periods with a mentor present is also something to consider.

These studies combined with our formative evaluation results, yield four elements to highlight when building laboratory QMS and capacity through mentorship. First, it is critical to have a standardized tool, like the LQSI, to guide laboratorians through identifying possible quality management actions with standardized templates and examples for those actions. All mentees, regardless of their laboratories’ NIC status or capacity, reported that the LQSI tool was advantageous in helping them develop their action plans and did not report any challenge or disadvantage to using it.

Second, providing a standardized and thorough baseline assessment of the laboratory’s general capacity through a tool like the CDC-APHL international influenza laboratory capacity review tool is a necessary part of action plan development. As discussed, an advantage to combining these two tools and approaches is that the focus can remain on building technical levels of laboratory quality, such as SOPS and biosafety, rather than on accreditation, which may not be feasible in many developing contexts, and is beyond the control of individual laboratories [5, 17,18,19]. An immersive, work-based opportunity like the baseline assessment supports the third element to highlight - connecting the laboratory to a mentor whom they trust with appropriate time and expertise for follow-up of planned actions. We recommend face-to-face observation and support within a mentee’s laboratory environment for establishing realistic expectations and a trusting line of communication for follow-up. The length of time, frequency, and the type of staff included in a mentor’s laboratory assessment visit should be evaluated [3, 4, 18].

Fourth, to support QMS problem solving, it is as important to have the awareness and support of upper management, as it is to link the laboratory to effective implementing partners in the region, as some factors are beyond the control of the mentees, such as laboratory space and procurement issues. Mentors and stakeholders in this evaluation noted that a lack of awareness and support for issues beyond their control might have contributed to action steps falling behind schedule, and this was the most common explanation of heterogeneity in progress made. While some mentees created small organizational changes such as establishing a quality assurance officer or team, the fact that mentorship occurs at the level of mentees, creates some challenges for organizational change. Similarly, Peronne et al. also reports that several management challenges exist around enforcing habits of quality assurance. They highlight the need for strong leadership from laboratory directors and hospital management, whom they explain may have assumed their positions due to their technical skills or seniority, and not had a chance for appropriate laboratory management experience [5]. One recommendation from the SLIPTA evaluation, which may help implementation, is paying more attention at the start of the program to ensure that participating laboratories have available, “a national laboratory strategic plan and policy, a laboratory director with decision making power, a quality assurance manager, and that participants are committed to the same job responsibilities during the program time frame” [18]. It is also important to consider creating an action plan that is flexible in allowing laboratories and mentors to adjust the schedule, so that when issues occur in one area, they can shift focus to another, until addressing the original issue.


While the progress on overall quality improvement was easy for mentors and mentees to discern through the action plan, they reported that understanding their progress towards the specific NIC requirements was more difficult for them to discern (n = 6/6 mentees, n = 4/4 mentors). Therefore, it is important that in future mentorship programs, clear steps and standards for NIC requirements are understood for better performance monitoring.


The regional mentorship program for influenza diagnostic laboratories in Southeast Europe serves as an initial proof of concept that significant accomplishments are achieved when quality implementation programs provide mentorship. We found that 61% of planned action steps were complete after 1 year. The mentorship program enhanced accountability for implementing planned actions and increased awareness of the importance of quality management processes in a laboratory, extending beyond the influenza laboratory. Moreover, both mentees and mentors perceived the mentorship program as beneficial to addressing barriers to laboratory quality improvement, and stakeholders were satisfied with the progress made. Since the start of the mentoring program, Laboratory “B” has achieved NIC recognition, while two other labs made substantial progress and are scheduled for recognition in 2018 (Laboratory “F”) and the first quarter of 2019 (Laboratory “D” and “E”). Meanwhile, NIC-Albania annually maintains the status of WHO recognition. In reaction, CDC and APHL have launched a new mentorship program with ten countries in the Africa region. Based on lessons learned from this evaluation, laboratory capacity assessments and LQSI tool training are continuing to help action plan development. To improve upon the program, they introduced a standardized template to support regular reporting of progress and challenges, including specific items for NIC terms of reference, and a collaborative online platform with shared resources. Performance monitoring that relates to NIC designation, such as timely sharing of clinical specimens with WHO Collaborating Centers for seasonal influenza vaccine strain selection and sharing of weekly virologic monitoring data through WHO GISRS, are being actively monitored to give feedback to mentors and mentees along the course of the program. Although challenging, the new program has asked senior leaders within the national laboratories to not only formally acknowledge their staffs’ participation in the program, but to do so by committing to support the time and work it requires of their staff and to review updates reported from the program.



Association of Public Health Laboratories


Centers for Disease Control and Prevention


WHO Regional Office for Europe


Global Influenza Surveillance and Response System


International Organization for Standards


Laboratory Quality Stepwise Implementation Tool


National Influenza Centers


Quality Assurance


Laboratory quality management systems


South East European Center of  Infectious Disease


WHO Collaborating Centers


  1. Glaser BG, Strauss AL. The purpose and credibility of qualitative research. Nurs Res. 1966;15(1):56–61.

    Article  CAS  Google Scholar 

  2. Lingard L, Albert M, Levinson W. Grounded theory, mixed methods, and action research. BMJ. 2008;337:a567.

    Article  Google Scholar 

  3. World Health Organization, Core Terms of Reference for WHO Collaborating Centers for Reference and Research on Influenza. 2006.

  4. WHO Regional Office for Europe, C.S.B. Brown, and D. Pereyaslov, How to become a WHO-recognized Influenza Centre: Guidance on the process for influenza laboratories in the WHO European Region. 2010.

  5. Krippendorff K. Content Analysis: An introduction to its methodology. 2nd ed. Thousand Oaks: Sage; 2004.

    Google Scholar 

  6. Jacelon CS, O'Dell KK. Case and grounded theory as qualitative research methods. Urol Nurs. 2005;25(1):49–52.

    PubMed  Google Scholar 

  7. World Health Organization. Terms of reference for National Influenza Centers of the global influenza surveillance and response system. 2017; Available from:

  8. Olmstead S. Strengthenig laboratory management systems in resource-limited settings. Am J Clin Psychol. 2010;134:374–80.

    Google Scholar 

  9. Yao K, et al. Improving quality management systems of laboratories in developing countries: an innovative training approach to accelerate laboratory accreditation. Am J Clin Pathol. 2010;134(3):401–9.

    Article  Google Scholar 

  10. Maruta T, et al. Impact of mentorship on WHO-AFRO strengthening laboratory quality improvement process towards accreditation (SLIPTA). Afr J Lab Med. 2012;1(1):6.

    PubMed  PubMed Central  Google Scholar 

  11. Johnson LE, et al. Capacity building in national influenza laboratories--use of laboratory assessments to drive progress. BMC Infect Dis. 2015;15:501.

    Article  Google Scholar 

  12. Perrone LA, et al. Implementation research: a mentoring programme to improve laboratory quality in Cambodia. Bull World Health Organ. 2016;94(10):743–51.

    Article  Google Scholar 

  13. Centers for Disease Control and Prevention and Association of Public Health Laboratories. International Influenza Laboratory Capacity Review Tool. 2012; rd:[Available from:

  14. World Health Organization. Laboratory stepwise quality implementation tool. 2015.

  15. Alemnji GA, et al. Strengthening national health laboratories in sub-Saharan Africa: a decade of remarkable progress. Tropical Med Int Health. 2014;19(4):450–8.

    Article  CAS  Google Scholar 

  16. Campbell J, et al. Coding in-depth semi-structured interviews: problems of unitization and intercoder reliability and agreement. Sociological Methods and Research. 2013;42(3):294–320.

    Article  Google Scholar 

  17. Stauss A, Corbin J. Basics of grounded theory methods. Beverly Hills: Sage; 1990.

    Google Scholar 

  18. World Health Organization, Terms of Reference for National Influenza Centres. 2014.

    Google Scholar 

  19. Hodson R. Analyzing documentary accounts. Thousand Oaks: Sage; 1999.

    Book  Google Scholar 

  20. Abimiku A. Turning the corner on laboratory systems and quality of laboratory testing in Africa. In: African society for laboratory management; 2012.

    Google Scholar 

  21. WHO Regional Office For Africa. Guide for the stepwise laboratory improvement process towards accreditation in the African region (SLIPTA). 2015; Available from:

Download references


The authors would like to thank Dr. Caroline Brown and Dr. Dmitriy Pereyaslov for their support and encouragement for this project. We would also like to thank Tjeerd Datema and Linda Oskam for their involvement in the project and training on the LSQI tool. Additionally, thank you to the national influenza laboratories that participated in this program: National Institute of Public Health Albania; The Public Health Institute of Republika Srpska, Bosnia and Herzegovina; National Institute of Public Health of Kosovo*; Laboratory for virology and molecular diagnostics, Institute of Public Health, Republic of Macedonia**; Center for Medical Microbiology, Institute of Public Health, Montenegro; Clinical University Centre of Sarajevo, Bosnia and Herzegovina. And finally, we are so grateful to the mentors who have developed strong relationships with the laboratories they mentored and have provided wonderful technical guidance throughout the program: Jayme Parker, Dr. Norma Tavakoli, Erik Reisdorf, and Richard Alexander. This evaluation project was made possible by the established CDC extramural, “non-research” Cooperative Agreement U60HM000803 and NU60OE000103, with no outside funding.

*Kosovo: in accordance with Security Council resolution 1244 (1999)..

**the former Yugoslav Republic of Macedonia in accordance with Security Council resolution 817 (1993).


The funding information is not applicable. No funding was received.

Availability of data and materials

The datasets generated and/or analyzed as a part of the program evaluation are not publicly available due to their qualitative nature and specificity to the program; however, on reasonable request, they are available from the corresponding author. This is necessary to protect participant confidentiality and trust in the program evaluation process. We believe that the final summary of raw data, through report and transcript coding, and through analysis of themes and de-identified, representative quotes, should be sufficient. Furthermore, we believe this is necessary to ensure confidentiality, and prevent deduction of the identity of the respondent through analysis of the entire coded transcript. If a researcher is interested in the raw data; however, they may contact the author to discuss their reasons and the way that the data would be used.

Author information

Authors and Affiliations



LP was responsible for the conceptual design of the evaluation, acquisition and analysis of data and its interpretation, incorporating important intellectual content into the manuscript and revising the manuscript. SC made substantial contributions to conceptual design of the evaluation, collection of data, and the drafting and revising of the manuscript. MW was critical to the analysis of the data set and its interpretation. TA, PK and SSB also made substantial contributions to the acquisition of data and revisions to the manuscript. Finally, AM was critical to the initiation of the evaluation, the conceptual design, and revising the manuscript for important programmatic content. All authors have read and approved the manuscript.

Corresponding author

Correspondence to Lauren Polansky.

Ethics declarations

Ethics approval and consent to participate

Informed consent from participants who participated in the evaluation of the mentorship program was obtained from all participants in written form prior to the commencement of the evaluation and again in written form prior to each interview. CDC, APHL, and WHO classified this case study as extramural, “non-research,” as approved by Cooperative Agreement # U60HM000803 and NU60OE000103. The evaluation case study fulfills a performance evaluation requirement of the non-research cooperative agreement, which deems the need for IRB ethics approval in this evaluation unnecessary through its designation as program evaluation for “non-research.” As such, the qualitative transcripts and themes that comprise this evaluation case study are a part of routine internal performance monitoring and evaluation and therefore are not publicly available.

Consent for publication

All participants voluntarily gave their informed consent for publication in written form.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Additional file

Additional file 1:

Summary of Interview Questions. Examples of the interview questions used during the evaluation. (DOCX 28 kb)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Polansky, L., Chester, S., Warren, M. et al. Can mentorship improve laboratory quality? A case study from influenza diagnostic laboratories in Southeast Europe. BMC Health Serv Res 19, 49 (2019).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: